LanzaTech Global, Inc. (LNZA)
NASDAQ: LNZA · IEX Real-Time Price · USD
2.000
-0.030 (-1.48%)
At close: Jun 17, 2024, 4:00 PM
2.070
+0.070 (3.50%)
After-hours: Jun 17, 2024, 6:21 PM EDT
Company Description
LanzaTech Global, Inc. operates as a nature-based carbon refining company in the United States and internationally.
The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging.
It is also developing biocatalysts and processes to produce a suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (IPA) and industrial solvents used in various applications, including production of polymers from IPA.
LanzaTech Global, Inc. was founded in 2005 and is headquartered in Skokie, Illinois.
LanzaTech Global, Inc.
Country | United States |
Founded | 2005 |
Industry | Waste Management |
Sector | Industrials |
Employees | 414 |
CEO | Dr. Jennifer Holmgren Ph.D. |
Contact Details
Address: 8045 Lamon Avenue, Suite 400 Skokie, Illinois 60077 United States | |
Phone | 847-324-2400 |
Website | lanzatech.com |
Stock Details
Ticker Symbol | LNZA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001843724 |
CUSIP Number | 51655R101 |
ISIN Number | US51655R1014 |
Employer ID | 86-1763050 |
SIC Code | 2860 |
Key Executives
Name | Position |
---|---|
Dr. Jennifer Holmgren Ph.D. | Chair of the Board and Chief Executive Officer |
Dr. Sean Simpson | Co-Founder and Strategic Advisor |
Geoffrey Trukenbrod | Chief Financial Officer |
Aura Maria Cuellar Calad | President |
Dr. Robert Conrado Ph.D. | Chief Technology Officer |
Nilesh Kumar | Chief Information Security Officer |
Dr. Zara Summers | Chief Science Officer |
Joseph C. Blasko BSFS, J.D. | General Counsel and Corporate Secretary |
Omar El-Sharkawy | Vice President of Corporate Development |
Johann Clere | Vice President of Commercial Strategy and Marketing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 16, 2024 | ARS | Filing |
May 9, 2024 | 424B3 | Prospectus |
May 9, 2024 | S-3 | Registration statement under Securities Act of 1933 |
May 9, 2024 | 10-Q | Quarterly Report |
May 9, 2024 | 8-K | Current Report |
Apr 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
Apr 29, 2024 | 8-K | Current Report |
Apr 23, 2024 | EFFECT | Notice of Effectiveness |
Apr 23, 2024 | 424B7 | Filing |